Braun Perfusor Space User Manual

9
PATIENT SAFETY
• Access to the pump settings can be prohibited by DataLock 3. The code for
DataLock level 3 should differ from the one for levels 1 and 2 in case the
pump is only allowed to be used by pain management professionals.
•
For additional safety the removal of the syringe can be prevented by the use
of the Syringe Anti Removal Cap (see accessories) and the locking of the
syringe holder. The Syringe Anti Removal Cap is usable for the following
syringes: B. Braun Original Perfusor Syringe 50 ml, B. Braun Omnifix 50 ml,
BD Plastipak 50/60 ml and Tyco Monoject 50 ml. The locking of the syringe
holder is under the pump and is locked by a clockwise turn of 90°. Make sure
the syringe holder is safely locked. Opening of the syringe holder may not be
possible after locking.
•
In case opioids are administered and the Syringe Anti Removal Cap is not in
use and the syringe holder is not locked the therapy only should be
performed under surveillance of medical staff. This especially is necessary in
case non-authorised access to the drug can be anticipated.
•
When ending PCA and starting it again the therapy data are set to default
values.
•
Using the demand button also the patient is a permitted user. With the
demand button only a PCA-bolus can be requested. This is limited to pre-
defined doses by drug list and pump settings.
•
Consider startup characteristics before using low infusion rates (0.1ml/h)
with critical drugs.
Safety instructions for using TCI
•
TCI should only be performed by experienced anaesthetists being familiar
with the principles of TCI and properly trained in using the present device.
•
The use of TCI with B. Braun Space does not limit the responsibility of the
anaesthetist for administration of drugs. They need to be fully aware of the
available literature for any parameter set used in association with a drug and
need to refer to the prescribed information for rate and dosing limits.
•
Pharmacokinetic and pharmacodynamic interactions among anaesthetic
drugs are known, but are not taken into account into the calculation of the
plasma and effect site concentrations. They have to be taken into account by
the user.
•
In particular, the user must be aware that starting the TCI will result in the
automatic infusion of a pre-calculated bolus dose followed by an infusion to
achieve the selected target concentration.
•
It is essential that the user verifies that the patient characteristics and the
selected target concentration as well as the resulting dosages conform to the
prescribing information of the relevant country.
•
B. Braun has verified the accuracy of the mathematical model
implementation, the usability as well as pump delivery accuracy.

Braun Perfusor Space Specifications

General

Brand	Braun
Model	Perfusor Space
Category	Health Care Products
Language	English